San Antonio — Galena Biopharma, a Bay Area biotech that has been developing a cancer vaccine created by a San Antonio researcher, is merging with another immunotherapy company: Sellas Life Sciences Group, which will also be the name of the combined business. Sellas Life Sciences is developing multiple experimental cancer immunotherapies, including a treatment for […]
NYS Entity Status
NYS Filing Date
MAY 06, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2013 - GALENA BIOPHARMA, INC.
Around the Web
- Experimental Drug With San Antonio Roots Changes Home After Merger
By David Holley - Tuesday Aug 8, 2017
- NY AG presses TransUnion, Experian for cybersecurity details
By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017
ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.
- Landos Biopharma Raises $10 Million in Series A Financing
By Business Wire - Thursday Sep 21, 2017
PRESS RELEASE: Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced today it has raised $10 million in a Series A financing led by life sciences investment...
- Inside a Secretive Group Where Women Are Branded
By BARRY MEIER - Wednesday Oct 18, 2017
A self-help organization in Albany called Nxivm has begun to unravel as members reveal disturbing practices and fears of blackmail.
- Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More
By Alex Lash - Friday Aug 11, 2017
With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital. The FDA reported that generic drug approvals are set to hit a record; the agency under Commissioner Scott […]